Status:
COMPLETED
Russian Kogenate Pediatric Study
Lead Sponsor:
Bayer
Conditions:
Hemophilia A
Eligibility:
MALE
1-12 years
Phase:
PHASE4
Brief Summary
A prospective study to evaluate the effect of rFVIII-FS in different prophylactic regimens on bleeding events frequency and development of arthropathy in Previously Treated and Minimally treated Hemop...
Eligibility Criteria
Inclusion
- Male
- Severe hemophilia A or moderate hemophilia A
- 1-12 years of age
- Requiring treatment with FVIII
Exclusion
- Current or prior inhibitor or familial antecedents of inhibitor
- Surgery required during the study (9 months)
- Positive for HIV
Key Trial Info
Start Date :
June 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2009
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT00632814
Start Date
June 1 2007
End Date
September 1 2009
Last Update
July 1 2015
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Kirov, Russia, 610 027
2
Moscow, Russia, 105077
3
Saint Petersburg, Russia, 191186
4
Yekaterinburg, Russia, 620149